Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Summary:
FDA approval of Rasonque marks a potential turning point for pancreatic cancer, with its molecular-glue approach nearly doubling survival in previously treated patients.
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
Summary:
BioNTech and Genentech halted a personalized mRNA cancer vaccine trial after more deaths in the treatment arm highlighted challenges in treating immune-cold colorectal tumors.
New ‘Google-like’ search engine can scan millions of cells for hidden RNA clues in seconds
Summary:
Malva – A new search platform that can search RNA across millions of cells in seconds, exposing mutations, pathogens and isoforms hidden in massive biological datasets
Lilly adds to immune drug pipeline with $2.9B Merida buyout
Summary:
Lilly is acquiring Merida for up to $2.9 billion to add a precision approach for selectively eliminating disease-causing autoantibodies to its growing immunology pipeline.
Young startups miss out on biotech venture funding rebound
Summary:
Biotech funding is rebounding, but MassBio warns that young startups are being squeezed out as investors favor later-stage assets and China’s pipeline accelerates.
